Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Antrin photoangioplasty safe and clinically active in PAD therapy

Sep. 2, 1999

Nortran and Hoechst Marion Roussel to develop new antiarrhythmic compounds

Sep. 1, 1999

Ouabain analogue LND-623 is a more effective and less toxic inotropic agent

Sep. 1, 1999

Spironolactone continues to provide benefits in patients with heart failure

Sep. 1, 1999

New cyclopentenopyridine derivatives from Banyu active as ETA antagonists

Sep. 1, 1999

CytRx initiates phase I/II study of Flocor for treatment of acute lung injury

Sep. 1, 1999

ETA antagonist TA-0201 protects against deleterious effects of MI in dogs

Aug. 31, 1999

Preclinical and mechanism of action studies support efficacy of the NHE-1 inhibitor cariporide

Aug. 31, 1999

Final results of REACH-1 now in, support efficacy of bosentan in CHF

Aug. 30, 1999

Still in the news: vasopeptidase inhibitor omapatrilat a protagonist in Barcelona

Aug. 30, 1999

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026